Atsuhiro Kawashima

4.0k citations
100 papers · 3.0k indexed · h-index 26

Atsuhiro Kawashima

97 papers receiving 2.9k citations

Peers

Atsuhiro Kawashima
Comparison fields: 5 of 95
  • Rheumatology 1.0k
  • Surgery 1.2k
  • Oncology 747
  • Hepatology 200
  • Immunology and Allergy 140
Replace Vicki Rubin Kelley with:
Vicki Rubin Kelley United States
Justin Cates United States
Morihisa Hirota Japan
Gary W. Mierau United States
Jukka Melkko Finland
Kalliopi Stefanaki Greece
Yuki Morimoto Japan
Christine Mallet France
Marco Gambarotti Italy
Huayong Zhang China
Atsuhiro Kawashima relative to Vicki Rubin Kelley United States Vicki Rubin Kelley's profile →
Citations per field
00.5×2.9×
Vicki Rubin Kelley · 1×
Citations per year

Countries citing papers authored by Atsuhiro Kawashima

Since Specialization
Citations

This map shows the geographic impact of Atsuhiro Kawashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuhiro Kawashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuhiro Kawashima more than expected).

Fields of papers citing papers by Atsuhiro Kawashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsuhiro Kawashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuhiro Kawashima. The network helps show where Atsuhiro Kawashima may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Atsuhiro Kawashima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Atsuhiro Kawashima Line = papers co-authored together Atsuhiro Kawashima links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20223
3 20201
4 20187
5 201739
6 201613
7 201617
8 20153
9 201320
10 20125
11 201222
12 20073
13 200719
14 200211
15 200121
16 19992
17 199918
18 19956
19 199317
20 199123

About Atsuhiro Kawashima

Atsuhiro Kawashima is a scholar working on Rheumatology, Hepatology and Pathology and Forensic Medicine, having authored 100 papers that have together received 3.0k indexed citations. Recurring topics across this work include IgG4-Related and Inflammatory Diseases (21 papers), Abdominal vascular conditions and treatments (10 papers), Neuroendocrine Tumor Research Advances (9 papers), Pancreatitis Pathology and Treatment (8 papers), Sarcoma Diagnosis and Treatment (7 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Liver Disease Diagnosis and Treatment (7 papers) and Soft tissue tumor case studies (6 papers). The work is most often cited by research in Rheumatology (1.0k citations), Surgery (1.2k citations) and Oncology (747 citations). Atsuhiro Kawashima has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Satomi Kasashima, Yoh Zen, Yasushi Matsumoto, Masamitsu Endo, Fuminori Kasashima, Isao Nakanishi, Yoshio Oda, Yasuni Nakanuma, Kengo Kawakami and Kazuo Kasahara. Their work appears in journals such as SHILAP Revista de lepidopterología, Hepatology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026